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Sarac and colleagues give us an honest appraisal of their
experience with SilverHawk atherectomy (FoxHollow Technolo-
gies, Redwood City, Calif) for occlusive disease causing limb threat
(83%) or claudication (17%). Their general dissatisfaction with the
technique emanates from a low observed limb salvage rate of 75%
at 1 year, especially in patients presenting with tissue loss. Their
compromised results, and those of other single-center studies,
contrast the early favorable atherectomy outcomes from the Treat-
ing Peripherals with SilverHawk: Outcomes Collection (TALON)
registry. A number of factors contribute to outcome variability,
including study design (single-center vs multicenter, retrospective
vs prospective, consecutive vs noncontinuous patient series), pre-
dominant ischemic symptom (claudication vs limb threat), ana-
tomic disease severity (TransAtlantic Inter-Society Consensus clas-
sification), completeness and length of follow-up, and how
patients were selected for the treatment.
This last factor is not well described—nor evident—in many
reports and can result in a rather myopic view intrinsic to most
single-technique (monotherapy) reports. Without providing a
more complete picture of how all patients with limb ischemia are
managed at a reporting institution (ie, all therapies offered), the
reader is deprived of important details related to patient selection.
Ultimately, we want to know what is the best therapy to apply to
which patients.
With the multitude of available endovascular techniques, in-tional and laser atherectomy, stent, and stent graft, which are
effective and should we consider implementing into our revascu-
larization armamentaria? Should we always proceed with an endo-
first approach—or alternatively, bypass first for those resisting
catheter-based options—or wait for a better-tailored selection
algorithm? Unfortunately, such a selection algorithm does not
currently exist.
Most of us are willing to accept the retrospective nature of
most reports and any inherent individual surgeon and institu-
tional biases associated with a description of multiple treatment
options. These biases can be minimized using univariate and
multivariate statistical analyses to identify prognostic factors
associated with observed outcome differences between treat-
ments and patient subgroups. Reports that delineate specific
failure modes of individual therapies can also provide useful
decision-making information.
Although diabetes and tobacco abuse are common in most
peripheral arterial disease patients and therefore are not useful
discriminators of outcomes, Sarac et al have identified renal disease
and tissue loss as predictors of lower postatherectomy patency and
limb salvage. It appears that atherectomy provides suboptimal
improvements in limb perfusion for patients with advanced tissue
loss and that more complete revascularization by bypass construc-
tion may be preferred. Much more of the larger algorithm puzzle
remains to be solved.
